Compliance of an elderly hip fracture population with secondary preventative measures. Efficacy of a simple clinical practice intervention.
AffiliationDepartment of Trauma and Orthopaedic Surgery, Cork University Hospital, Cork,, Ireland. firstname.lastname@example.org
Aged, 80 and over
Hip Fractures/etiology/*prevention & control
MetadataShow full item record
CitationActa Orthop Belg. 2006 Apr;72(2):204-9.
JournalActa orthopaedica Belgica
AbstractSecondary pharmaceutical measures are effective in all age groups for the prevention of osteoporotic fractures. This prospective study determines the demographics of 566 consecutive osteoporotic hip fractures presenting to a Level 1 Trauma Center. We examine the efficacy of simple treatment recommendations for pharmaceutical treatment of osteoporosis and the factors determining general practitioner and patient compliance with these recommendations in a community setting. One out of four patients (24.5%) had sustained a previous fragility fracture. Mean age was 80 years. Twenty five percent were resident in a nursing home and only 10% were taking anti-resorptive therapy preoperatively. In hospital mortality was 6%, and 39% of recruited patients were dead at 12 months. By this time more than half the survivors were resident in a nursing home. The compliance with anti-resorptive therapy had increased to over 70% consequent to our simple recommendations. Significant differences in GP and patient compliance were observed between nursing home and own residence dwellers. This study demonstrates the efficacy of a simple clinical practice intervention in increasing patient and GP compliance with secondary fracture prevention measures. We also discuss many of the confounding issues determining this compliance.
- [Osteoporosis prevention in general practice after hospitalization for hip fracture].
- Authors: Wiboe L, Jacobsen IB, Mogensen CB
- Issue date: 2002 May 13
- Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
- Authors: Adachi JD, Hanley DA, Lorraine JK, Yu M
- Issue date: 2007 Sep
- Prevention and treatment of senile osteoporosis and hip fractures.
- Authors: Duque G, Demontiero O, Troen BR
- Issue date: 2009 Feb
- [Why do we close our eyes while the world is falling? A study on proximal femur osteoporotic fractures in a Portuguese population].
- Authors: Cruz M
- Issue date: 2009 Apr-Jun
- The osteoporosis needs of patients with wrist fracture.
- Authors: Bogoch ER, Elliot-Gibson V, Escott BG, Beaton DE
- Issue date: 2008 Sep